A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000
Sunil BhandariDepartment of Renal Medicine, Hull and East Yorkshire Hospitals National Health Service Trust and Hull York Medical School, Kingston upon Hull, UKBackground: The clinical need to be able to administer high doses of intravenous iron conveniently in a single rapid infusion has been addre...
Saved in:
Main Author: | Sunil Bhandari (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000
by: Pollock RF, et al.
Published: (2017) -
Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease
by: Nordfjeld K, et al.
Published: (2012) -
Intravenous Iron Isomaltoside 1000 Reduces Postoperative Anemia in Patients Undergoing Elective Urologic Surgery and Those with Urosepsis
by: Goh HJ, et al.
Published: (2020) -
Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice
by: Bhandari S
Published: (2011) -
Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
by: Guy Rostoker, et al.
Published: (2022)